Novel serial positive enrichment technology enables clinical multiparameter cell sorting - Wikidata - wikimedia - TriplyDB

Novel serial positive enrichment technology enables clinical multiparameter cell sorting

Novel serial positive enrichment technology enables clinical multiparameter cell sorting

http://www.wikidata.org/entity/Q28730418

about

Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?Designing chimeric antigen receptors to effectively and safely target tumors Fundamentals and application of magnetic particles in cell isolation and enrichment: a review Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo.Driving allotolerance: CAR-expressing Tregs for tolerance induction in organ and stem cell transplantation.Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy.siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice.Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy.Chimeric Antigen Receptor T Cell Therapy in Hematology.Role of memory T cell subsets for adoptive immunotherapy.Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells.Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset composition.Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.Minimally manipulated murine regulatory T cells purified by reversible Fab Multimers are potent suppressors for adoptive T cell therapy.Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies.TIL 2.0: More effective and predictive T-cell products by enrichment for defined antigen specificities.Lymphocyte enrichment using CD81-targeted immunoaffinity matrix.Therapeutic T cell engineering.Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.Guidelines for the use of flow cytometry and cell sorting in immunological studies.Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy.Cell Separation in Aqueous Two-Phase Systems - Influence of Polymer Molecular Weight and Tie-Line Length on the Resolution of Five Model Cell Lines.Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8+ T cells.Clinical Grade Regulatory CD4+ T Cells (Tregs): Moving Toward Cellular-Based Immunomodulatory Therapies.

P2860

Q27002575-C02E4219-BD71-4428-BD1B-F4D5612E9E32 Q28088526-C5C82D3A-F650-47D0-90ED-72798D482F19 Q30395055-0BEBFAA9-B534-410A-8760-CBF9A89F4B77 Q34044910-29203CA2-5D77-4FB6-A31C-1B210D52D5BB Q34046493-4F4E8AAC-ED2E-4B7B-9D28-A8E63216579B Q34580132-042A2254-D44C-4CCF-849A-9E998E19B96B Q35546869-ED18E663-4839-4159-9373-502EADF6F4C0 Q36430680-BAD1666A-BDBE-4CD1-A7A6-6607CAC27FE5 Q36722700-AD3BF719-E71D-4E02-846A-485D7E7DD39B Q37263366-B9C46383-0A16-4C32-B0DD-26E9D7797B3D Q38170500-C4ADBD12-3713-4DF9-8F78-814412690567 Q38199350-38C884C7-E0A0-45DA-BF8E-45ACDF5BB66E Q38435415-D5853EA7-52BA-4532-95D4-4BDB5447F682 Q38638286-23EDE162-A9D1-4222-A49E-0BF8D01146BD Q38768392-6FFA2010-55AE-4963-BF9A-584D5E0C5234 Q38855909-6D0DCD31-6ED9-4E30-A42D-8D5BFE525036 Q39524857-5DE81CD6-1937-487A-B133-017F95C7E3CC Q40199809-B04F5E49-CA08-4A44-95FF-7A80F5A4698A Q40370932-5D85A807-1F30-453C-BEB2-49CC0F5F7495 Q41918189-7DC6E287-D03D-490A-96E9-1B6B24AB584F Q45875529-98AC7720-27DD-44E8-8B5E-4854874BD2F6 Q47178676-CE5EE9D2-9FD6-4D51-96AB-3C67A1298D46 Q50533781-C5D626BF-49E5-4A5F-AD8A-9D2693992909 Q52682313-DCF92E0F-8F64-4394-9A7F-CEDE2D929B08

P2860

Novel serial positive enrichment technology enables clinical multiparameter cell sorting

http://www.wikidata.org/entity/Q28730418

description

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

article publié dans la revue scientifique PLoS ONE

@fr

artículu científicu espublizáu en 2012

@ast

im Januar 2012 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: 2012)

@en

vedecký článok (publikovaný 2012)

@sk

vědecký článek publikovaný v roce 2012

@cs

wetenschappelijk artikel (gepubliceerd in 2012)

@nl

наукова стаття, опублікована у 2012

@uk

name

Novel serial positive enrichment technology enables clinical multiparameter cell sorting

@ast

Novel serial positive enrichment technology enables clinical multiparameter cell sorting

@en

Novel serial positive enrichment technology enables clinical multiparameter cell sorting

@nl

type

label

Novel serial positive enrichment technology enables clinical multiparameter cell sorting

@ast

Novel serial positive enrichment technology enables clinical multiparameter cell sorting

@en

Novel serial positive enrichment technology enables clinical multiparameter cell sorting

@nl

prefLabel

Novel serial positive enrichment technology enables clinical multiparameter cell sorting

@ast

Novel serial positive enrichment technology enables clinical multiparameter cell sorting

@en

Novel serial positive enrichment technology enables clinical multiparameter cell sorting

@nl

P1433

Q28730418-1282D176-096E-4CC6-8D61-F9BE1F7E7CBC

P1476

Q28730418-C36818A6-554F-40D4-A68D-8CCDB5E6C6DC

P2093

Q28730418-16570B96-BFDE-492A-9C18-7DBFFF35670F

Q28730418-2F594D8A-EE91-447F-8074-89E54AA093D1

Q28730418-33B1F397-E866-4883-B714-FA46B16453F1

Q28730418-55918EA2-22F1-430F-B51D-1A24524784A2

Q28730418-56996A25-0C82-4F87-92DE-E42028EB7E79

Q28730418-5796B7CB-BC1C-4C8F-9BEC-E3941654294E

Q28730418-5B791446-692F-41F2-A380-34B24FFA459D

Q28730418-6B16A820-6D25-49F1-99F6-1548AFFB4ED8

Q28730418-70E4FAC0-5565-4773-AFF9-CC7D60DD5550

Q28730418-7C1782AD-8341-4E35-8916-90183945F55A

P2860

Q28730418-175083F3-FB2A-49BC-A67C-EB96F8125D31

Q28730418-2F8F13C5-3FAA-49D0-AFCC-5FCB1F60284C

Q28730418-365CD12D-4D76-4342-8C6B-46CE2A1BB1CA

Q28730418-37BEF646-6242-4ABA-A213-EF51255E0D1F

Q28730418-489EE6D1-D3D1-418B-8B75-FE90A69CCD1F

Q28730418-59BAC157-814E-4759-8DA7-B3A5E312ED38

Q28730418-5DD4830E-3F07-462C-BA7C-E81D05079C5B

Q28730418-5F3E2D3A-7731-48A2-9E03-85D60B2255DB

Q28730418-5F4E796C-EA2B-455D-B66E-9B5E91D948F7

Q28730418-752CBAFC-0671-444B-B2B5-17E3020C5582

P304

Q28730418-300542E1-3495-4C2D-950F-D14BCEF7485C

P31

Q28730418-087736FA-3ACE-4FB4-A016-C1B3D31CA25C

P356

Q28730418-1F5BCE9E-94E1-4215-AAB2-6B821719ECC5

P407

Q28730418-1C319C1D-7702-43A8-A1F4-CB68C3426EDF

P433

Q28730418-1E299917-69BD-4CF1-BEB2-73DB34770E46

P478

Q28730418-CF526AA4-BC45-46A3-8ECE-757DC58221C8

P50

Q28730418-6F0916E9-BC42-4172-B52D-B4FDC962B949

Q28730418-E438DCC5-DFB5-4F73-84B2-8D557D48188A

Q28730418-E772F87E-1E7D-4BCC-AF23-763A2070473F

P577

Q28730418-31E19FA6-9D64-4C7D-8731-7E5FB001028F

P5875

Q28730418-8690E15C-3803-40C1-A874-57EFE0A1C359

P698

Q28730418-888D67E0-F142-4C6C-AC34-9BC48F0D54D5

P932

Q28730418-E8E6AAA9-9DB6-4088-A50C-6F560C0E8261

P356

JOURNAL.PONE.0035798

P1433

P1476

Novel serial positive enrichment technology enables clinical multiparameter cell sorting

@en

P2093

Christian Stemberger

http://www.w3.org/2001/XMLSchema#string

Christine Piossek

http://www.w3.org/2001/XMLSchema#string

Claudia Tschulik

http://www.w3.org/2001/XMLSchema#string

Dirk H Busch

http://www.w3.org/2001/XMLSchema#string

Jeannette Bet

http://www.w3.org/2001/XMLSchema#string

Klaus Martin

http://www.w3.org/2001/XMLSchema#string

Lothar Germeroth

http://www.w3.org/2001/XMLSchema#string

Matthias Schiemann

http://www.w3.org/2001/XMLSchema#string

Michael Neuenhahn

http://www.w3.org/2001/XMLSchema#string

Stanley R Riddell

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

Human T regulatory cell therapy: take a billion or so and call me in the morning

The rational construction of an antibody against cystatin: lessons from the crystal structure of an artificial Fab fragment

Phenotypic analysis of antigen-specific T lymphocytes

TGN1412: From Discovery to Disaster

Cloning immunoglobulin variable domains for expression by the polymerase chain reaction

The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins.

Crystal structure of the human T cell receptor CD3 epsilon gamma heterodimer complexed to the therapeutic mAb OKT3.

CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease

In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells.

P304

e35798

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0035798

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Matthias Edinger

Martin Schlapschy

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224868744

http://www.w3.org/2001/XMLSchema#string

P698

22545138

http://www.w3.org/2001/XMLSchema#string

P932

3335788

http://www.w3.org/2001/XMLSchema#string